Application 206857
- Type
- ANDA
- Sponsor
- WILSHIRE PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TIAGABINE HYDROCHLORIDE | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 2MG | No | No |
| 002 | TIAGABINE HYDROCHLORIDE | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 4MG | No | No |
| 003 | TIAGABINE HYDROCHLORIDE | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 12MG | No | No |
| 004 | TIAGABINE HYDROCHLORIDE | TIAGABINE HYDROCHLORIDE | TABLET;ORAL | 16MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 52536-350 | tiagabine hydrochloride | tiagabine hydrochloride | Wilshire Pharmaceuticals, Inc. | ANDA | Current |
| 52536-350 | tiagabine hydrochloride | tiagabine hydrochloride | Wilshire Pharmaceuticals, Inc. | ANDA | Current |
| 52536-355 | tiagabine hydrochloride | tiagabine hydrochloride | Wilshire Pharmaceuticals, Inc. | ANDA | Current |
| 52536-355 | tiagabine hydrochloride | tiagabine hydrochloride | Wilshire Pharmaceuticals, Inc. | ANDA | Current |
| 52536-360 | tiagabine hydrochloride | tiagabine hydrochloride | Wilshire Pharmaceuticals, Inc. | ANDA | Current |
| 52536-360 | tiagabine hydrochloride | tiagabine hydrochloride | Wilshire Pharmaceuticals, Inc. | ANDA | Current |
| 52536-365 | tiagabine hydrochloride | tiagabine hydrochloride | Wilshire Pharmaceuticals, Inc. | ANDA | Current |
| 52536-365 | tiagabine hydrochloride | tiagabine hydrochloride | Wilshire Pharmaceuticals, Inc. | ANDA | Current |